New Zealand - Hospital Average Length of Stay for Malignant Neoplasm of Bladder
Since 2014, New Zealand Hospital Average Length of Stay for Malignant Neoplasm of Bladder fell by 3% year on year. With 4.8 Days in 2019, the country was number 23 among other countries in Hospital Average Length of Stay for Malignant Neoplasm of Bladder. New Zealand is overtaken by Spain, which was ranked number 22 at 5.1 Days and is followed by Australia at 4.7 Days. South Korea topped the ranking with 11.3 Days in 2019, stable compared to 2018. Iceland witnessed the best average annual growth at +6.9% per year, while Mexico recorded the worst performance at -5% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 4.80 |
| 2018 | 4.90 |
| 2017 | 4.40 |
| 2016 | 5.90 |
| 2015 | 7.90 |
Download all data from 2000 to 2019
How does New Zealand rank in Hospital Average Length of Stay for Malignant Neoplasm of Bladder?
| # | 33 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
South Korea
|
11.30 | 2019 | +0.0 % | +0.7 % | View data | |
| 2 |
#2
Iceland
|
8.50 | 2019 | +2.4 % | +6.9 % | View data | |
| 22 |
#22
Spain
|
5.10 | 2019 | -1.9 % | +1.6 % | View data | |
| 23 |
#23
New Zealand
|
4.80 | 2019 | -2.0 % | -3.0 % | View data | |
| 24 |
#24
Australia
|
4.70 | 2019 | -2.1 % | -2.4 % | View data | |